New hope for controlling advanced leukemia with gentler treatment
NCT ID NCT07259161
Summary
This study is testing a new, less toxic combination of chemotherapy drugs (thiotepa and melphalan) for patients with an aggressive form of chronic myeloid leukemia (CML) called blast phase. The goal is to better control the disease and improve survival by preparing patients for a stem cell transplant with fewer severe side effects. The study will enroll 40 adults in China to see if this approach is safe and effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HSCT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.